Kukkonen JP - Search Results

1

Communication between the calcium and cAMP pathways regulate the expression of the TSH receptor: TRPC2 in the center of action.

Löf C, Sukumaran P, Viitanen T, Vainio M, Kemppainen K, Pulli I, Näsman J, Kukkonen JP, Törnquist K. Löf C, et al. Among authors: kukkonen jp. Mol Endocrinol. 2012 Dec;26(12):2046-57. doi: 10.1210/me.2012-1171. Epub 2012 Sep 26. Mol Endocrinol. 2012. PMID: 23015753 Free PMC article.

2

Autocrine endocannabinoid signaling through CB1 receptors potentiates OX1 orexin receptor signaling.

Jäntti MH, Putula J, Turunen PM, Näsman J, Reijonen S, Lindqvist C, Kukkonen JP. Jäntti MH, et al. Among authors: kukkonen jp. Mol Pharmacol. 2013 Mar;83(3):621-32. doi: 10.1124/mol.112.080523. Epub 2012 Dec 11. Mol Pharmacol. 2013. PMID: 23233488

3

Dual signalling by different octopamine receptors converges on adenylate cyclase in Sf9 cells.

Näsman J, Kukkonen JP, Akerman KE. Näsman J, et al. Among authors: kukkonen jp. Insect Biochem Mol Biol. 2002 Mar 1;32(3):285-93. doi: 10.1016/s0965-1748(01)00089-3. Insect Biochem Mol Biol. 2002. PMID: 11804800

4

Functional properties of muscarinic receptor subtypes Hm1, Hm3 and Hm5 expressed in Sf9 cells using the baculovirus expression system.

Kukkonen JP, Näsman J, Ojala P, Oker-Blom C, Akerman KE. Kukkonen JP, et al. J Pharmacol Exp Ther. 1996 Nov;279(2):593-601. J Pharmacol Exp Ther. 1996. PMID: 8930161

5

Protean agonism at alpha2A-adrenoceptors.

Jansson CC, Kukkonen JP, Näsman J, Huifang G, Wurster S, Virtanen R, Savola JM, Cockcroft V, Akerman KE. Jansson CC, et al. Among authors: kukkonen jp. Mol Pharmacol. 1998 May;53(5):963-8. Mol Pharmacol. 1998. PMID: 9584224

6

Agonist potency differentiates G protein activation and Ca2+ signalling by the orexin receptor type 1.

Magga J, Bart G, Oker-Blom C, Kukkonen JP, Akerman KE, Näsman J. Magga J, et al. Among authors: kukkonen jp. Biochem Pharmacol. 2006 Mar 14;71(6):827-36. doi: 10.1016/j.bcp.2005.12.021. Epub 2006 Jan 20. Biochem Pharmacol. 2006. PMID: 16430869

7

Adrenoceptor activity of muscarinic toxins identified from mamba venoms.

Näreoja K, Kukkonen JP, Rondinelli S, Toivola DM, Meriluoto J, Näsman J. Näreoja K, et al. Among authors: kukkonen jp. Br J Pharmacol. 2011 Sep;164(2b):538-50. doi: 10.1111/j.1476-5381.2011.01468.x. Br J Pharmacol. 2011. PMID: 21557730 Free PMC article.

8

Orexin/hypocretin receptor chimaeras reveal structural features important for orexin peptide distinction.

Putula J, Turunen PM, Johansson L, Näsman J, Ra R, Korhonen L, Kukkonen JP. Putula J, et al. Among authors: kukkonen jp. FEBS Lett. 2011 May 6;585(9):1368-74. doi: 10.1016/j.febslet.2011.04.020. Epub 2011 Apr 15. FEBS Lett. 2011. PMID: 21510948 Free article.

9

Alpha2B-adrenoceptors couple to Ca2+ increase in both endogenous and recombinant expression systems.

Holmberg CI, Kukkonen JP, Bischoff A, Näsman J, Courtney MJ, Michel MC, Akerman KE. Holmberg CI, et al. Among authors: kukkonen jp. Eur J Pharmacol. 1998 Dec 11;363(1):65-74. doi: 10.1016/s0014-2999(98)00780-8. Eur J Pharmacol. 1998. PMID: 9877083

10

Muscarinic receptor subtypes in human neuroblastoma cell lines SH-SY5Y and IMR-32 as determined by receptor binding, Ca++ mobilization and northern blotting.

Kukkonen J, Ojala P, Näsman J, Hämäläinen H, Heikkilä J, Akerman KE. Kukkonen J, et al. J Pharmacol Exp Ther. 1992 Dec;263(3):1487-93. J Pharmacol Exp Ther. 1992. PMID: 1335069

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page